Solasia Pharma KK (4597)

Currency in JPY
31.0
+1.0(+3.33%)
Delayed Data·
Earnings results expected in 3 days
4597 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.031.0
52 wk Range
21.044.0
Key Statistics
Bid/Ask
30.00 / 31.00
Prev. Close
30
Open
30
Day's Range
30-31
52 wk Range
21-44
Volume
27.78M
Average Volume (3m)
72.71M
1-Year Change
-20.5128%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4597 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-1.14 / --
Revenue / Forecast
6M / --
EPS Revisions
Last 90 days

4597 Income Statement

Compare 4597 to Peers and Sector

Metrics to compare
4597
Peers
Sector
Relationship
P/E Ratio
−9.2x−8.9x−0.4x
PEG Ratio
−0.15−0.310.00
Price/Book
4.8x2.7x2.6x
Price / LTM Sales
20.0x28.1x3.1x
Upside (Analyst Target)
-177.0%48.5%
Fair Value Upside
Unlock1.4%5.8%Unlock

Solasia Pharma K.K. develops, markets, imports, and exports pharmaceutical products and medical devices in Japan, China, South Korea, and internationally. The company offers Episil (SP-03), an oral liquid for oral mucositis/stomatitis; DARVIAS (SP-02), an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma; and Sancuso (SP-01) for chemotherapy-induced nausea and vomiting. It also develops SP-04, which is in a preclinical trial for chemotherapy-induced peripheral neuropathy; and SP-05, which is in a preclinical trial for colorectal cancer. The company was formerly known as JapanBridge, Inc. and changed its name to Solasia Pharma K.K. in September 2008. Solasia Pharma K.K. was founded in 2006 and is headquartered in Minato, Japan.

Employees
22
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
844.30K0.31%25.33M
Other Institutional Investors
41.39M15.16%1.24B
Public Companies & Retail Investors
230.77M84.53%6.92B
Total
273M100.00%8.19B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nippon Kayaku Co., Ltd.4.40%12,000,000360,000
Maruho Co.,Ltd.4.15%11,324,000339,720

People Also Watch

49.0
6740
-2.00%
229.4
9434
-0.65%
48,340.00
285A
+1.28%
3,440.0
3778
0.00%
19.0
4564
-5.00%

FAQ

What Is the Solasia Pharma (4597) Stock Price Today?

The Solasia Pharma stock price today is 31.0 JPY.

What Stock Exchange Does Solasia Pharma Trade On?

Solasia Pharma is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Solasia Pharma?

The stock symbol for Solasia Pharma is "4597."

What Is the Solasia Pharma Market Cap?

As of today, Solasia Pharma market cap is 8.46B JPY.

What Is Solasia Pharma's Earnings Per Share (TTM)?

The Solasia Pharma EPS (TTM) is -3.6.

When Is the Next Solasia Pharma Earnings Date?

Solasia Pharma will release its next earnings report on Aug 13, 2026.

From a Technical Analysis Perspective, Is 4597 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Solasia Pharma Stock Split?

Solasia Pharma has split 0 times.

How Many Employees Does Solasia Pharma Have?

Solasia Pharma has 22 employees.

What is the current trading status of Solasia Pharma (4597)?

As of Aug 10, 2026, Solasia Pharma (4597) is trading at a price of 31.0 JPY, with a previous close of 30.0 JPY. The stock has fluctuated within a day range of 30.0 JPY to 31.0 JPY, while its 52-week range spans from 21.0 JPY to 44.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.